Beacon Investment Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-1,031
Closed -$554K 130
2023
Q3
$554K Buy
1,031
+7
+0.7% +$3.61K 0.39% 70
2023
Q2
$480K Hold
1,024
0.33% 80
2023
Q1
$352K Hold
1,024
0.26% 95
2022
Q4
$375K Buy
+1,024
New +$363K 0.31% 89

Other funds holding LLY

Beacon Investment Advisors's LLY Position: Q4 2023 in Review

Beacon Investment Advisors sold out of Eli Lilly (LLY) in Q4 2023, closing a stake of 1,031 shares — an estimated $554K sold.

Beacon Investment Advisors first reported a position in LLY in Q4 2022 and held it in 4 quarters. The position peaked at $554K in Q3 2023. 3,272 funds tracked by Wall St. Rank hold LLY as of Q4 2023.

  • Beacon Investment Advisors reported no remaining Eli Lilly position as of Q4 2023 after selling out during the quarter.
  • Beacon Investment Advisors sold 1,031 Eli Lilly shares in Q4 2023, an estimated $554K.
  • Beacon Investment Advisors first reported a position in Eli Lilly in Q4 2022 and held it in 4 quarters.
  • Beacon Investment Advisors's Eli Lilly position peaked at $554K in Q3 2023.
  • 3,272 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2023.

Based on Beacon Investment Advisors's 13F filing for Q4 2023, filed 13 Feb 2024.